LINETSKY DAVID (SVP, Life Sciences) sold 3.6% of their position (8.33K shares) of PHREESIA, INC. on the open market
Open‑market sale worth $67.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/14/2026ACC: 0001412408-26-000112
Officer· SVP, Life Sciences
Since Jul 2019
-18.70K
Net shares
Net seller
$162.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.70K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−9.45K
Price / share
$9.15
Trade value
$86.50K
% of position
3.9%
4/9/2026
241.84K→232.39K
Common Stock
Indirect
Shares
−914.00
Price / share
$9.15
Trade value
$8.36K
% of position
6.9%
4/9/2026
13.28K→12.36K
Common Stock
Direct
Shares
−8.33K
Price / share
$8.07
Trade value
$67.24K
% of position
3.6%
4/10/2026
232.39K→224.06K
Total
Net shares
−18.70K
Net value
-$162.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/9/2026 | F · Tax Withholding | −9.45K | $9.15 | $86.50K | 3.9% | 241.84K | 232.39K |
| Common Stock Indirect | 4/9/2026 | F · Tax Withholding | −914.00 | $9.15 | $8.36K | 6.9% | 13.28K | 12.36K |
| Common Stock Direct | 4/10/2026 | S · Sale | −8.33K | $8.07 | $67.24K | 3.6% | 232.39K | 224.06K |
| Total | −18.70K | -$162.11K | ||||||
Derivative Transactions0
No derivative transactions reported